- Skin rash as useful marker of erlotinib efficacy in NSCLC and its impact on clinical practice2013 | Faculty of Medicine in Pilsen
- Severe abdominal pain: an atypical initial and leading symptom preceding skin rash in Henoch-Schönlein purpura2023 | Faculty of Medicine in Pilsen, Central Library of Charles University
- Serum Concentration of Erlotinib and its Correlation with Outcome and Toxicity in Patients with Advanced-stage NSCLC2017 | Faculty of Medicine in Pilsen, First Faculty of Medicine, Faculty of Science
- Viral illness with blistering, diagnostics and therapy2013 | Faculty of Medicine in Hradec Králové
- Prurigo Pigmentosa - Case Report2018 | First Faculty of Medicine
- Clinical and biochemical characteristics of Kawasaki syndrome in 22 children2014 | First Faculty of Medicine
- Dermatomyositis with anti-TIF-1γ antibodies as a presenting symptom of underlying triple-negative breast cancer: a case report2016 | Faculty of Medicine in Hradec Králové
- Nivolumab-induced hepatitis in a patient treated for malignant melanoma2020 | Faculty of Medicine in Pilsen
- Patient with fever and rash at the enmergency department2023 | Faculty of Medicine in Pilsen
- Is It the Twilight of BACEI Inhibitors?2021 | Publication without faculty affiliation
- Pemetrexed Versus Erlotinib in the Second-line Treatment of Patients with Advanced-stage Non-squamous NSCLC Harboring Wild-type EGFR Gene2016 | Faculty of Medicine in Pilsen, Faculty of Science
- Bilateral Syphylitic Chorioretinitis in a 33-year-old Pervitin User2011 | Second Faculty of Medicine
- Novel Somatic UBA1 Variant in a Patient With VEXAS Syndrome2023 | First Faculty of Medicine
- Comparison of EGFR-TKI and chemotherapy in the first-line treatment of advanced EGFR mutation-positive NSCLC2013 | Faculty of Medicine in Pilsen
- EFNS guideline on the management of community-acquired bacterial meningitis: report of an EFNS Task Force on acute bacterial meningitis in older children and adults2008 | Second Faculty of Medicine
- Dense genotyping of immune-related loci in idiopathic inflammatory myopathies confirms HLA alleles as the strongest genetic risk factor and suggests different genetic background for major clinical subgroups2016 | First Faculty of Medicine
- Vemurafenib for Refractory Multisystem Langerhans Cell Histiocytosis in Children: An International Observational Study2019 | Second Faculty of Medicine
